158 related articles for article (PubMed ID: 37178009)
41. Natalizumab for induction of remission in Crohn's disease.
Macdonald JK; McDonald JW
Cochrane Database Syst Rev; 2006 Jul; (3):CD006097. PubMed ID: 16856112
[TBL] [Abstract][Full Text] [Related]
42. Crohn's disease: an important differential diagnosis of granulomatous skin diseases.
Eames T; Landthaler M; Karrer S
Eur J Dermatol; 2009; 19(4):360-4. PubMed ID: 19443301
[TBL] [Abstract][Full Text] [Related]
43. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
44. Metastatic Crohn's disease of external genitalia.
Panackel C; John J; Krishnadas D; Vinayakumar KR
Indian J Dermatol; 2008; 53(3):146-8. PubMed ID: 19882017
[TBL] [Abstract][Full Text] [Related]
45. Adalimumab for maintenance of remission in Crohn's disease.
Townsend CM; Nguyen TM; Cepek J; Abbass M; Parker CE; MacDonald JK; Khanna R; Jairath V; Feagan BG
Cochrane Database Syst Rev; 2020 May; 5(5):CD012877. PubMed ID: 32413933
[TBL] [Abstract][Full Text] [Related]
46. Aminosalicylates for induction of remission or response in Crohn's disease.
Lim WC; Wang Y; MacDonald JK; Hanauer S
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD008870. PubMed ID: 27372735
[TBL] [Abstract][Full Text] [Related]
47. Histologic scoring indices for evaluation of disease activity in Crohn's disease.
Novak G; Parker CE; Pai RK; MacDonald JK; Feagan BG; Sandborn WJ; D'Haens G; Jairath V; Khanna R
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD012351. PubMed ID: 28731502
[TBL] [Abstract][Full Text] [Related]
48. [Diagnosis and treatment of Crohn's disease in children: 10 years' clinical experience].
Huang XL; Chen J; Ma M; Wang PX; Li ZY
Zhonghua Er Ke Za Zhi; 2007 Apr; 45(4):248-51. PubMed ID: 17706058
[TBL] [Abstract][Full Text] [Related]
49. Natalizumab for induction of remission in Crohn's disease.
MacDonald JK; McDonald JW
Cochrane Database Syst Rev; 2007 Jan; (1):CD006097. PubMed ID: 17253580
[TBL] [Abstract][Full Text] [Related]
50. Epidemiology and outcome of Crohn's disease in a teaching hospital in Riyadh.
Al-Ghamdi AS; Al-Mofleh IA; Al-Rashed RS; Al-Amri SM; Aljebreen AM; Isnani AC; El-Badawi R
World J Gastroenterol; 2004 May; 10(9):1341-4. PubMed ID: 15112355
[TBL] [Abstract][Full Text] [Related]
51. Natural history of children with mild Crohn's disease.
Sharma Y; Bousvaros A; Liu E; Bender Stern J
World J Gastroenterol; 2019 Aug; 25(30):4235-4245. PubMed ID: 31435176
[TBL] [Abstract][Full Text] [Related]
52. Successful treatment of oral Crohn's disease by anti-TNF-alpha dose escalation - a case report.
Bokemeyer A; Tentrop N; Barth PJ; Lenze F; Hengst K; Kleinheinz J; Bettenworth D
BMC Gastroenterol; 2018 Jun; 18(1):88. PubMed ID: 29914414
[TBL] [Abstract][Full Text] [Related]
53. Crohn's Disease of the Pouch: A True Diagnosis or an Oversubscribed Diagnosis of Exclusion?
Lightner AL; Fletcher JG; Pemberton JH; Mathis KL; Raffals LE; Smyrk T
Dis Colon Rectum; 2017 Nov; 60(11):1201-1208. PubMed ID: 28991085
[TBL] [Abstract][Full Text] [Related]
54. Clinical experience and diagnostic algorithm of vulval Crohn's disease.
Boxhoorn L; Stoof TJ; de Meij T; Hoentjen F; Oldenburg B; Bouma G; Löwenberg M; van Bodegraven AA; de Boer NKH;
Eur J Gastroenterol Hepatol; 2017 Jul; 29(7):838-843. PubMed ID: 28430699
[TBL] [Abstract][Full Text] [Related]
55. [Frequency and characteristics of granulomas in 368 pediatric patients with Crohn's disease].
Müller KE; Lakatos PL; Papp M; Veres G
Orv Hetil; 2013 Oct; 154(43):1702-8. PubMed ID: 24140509
[TBL] [Abstract][Full Text] [Related]
56. Enteral nutritional therapy for inducing remission of Crohn's disease.
Zachos M; Tondeur M; Griffiths AM
Cochrane Database Syst Rev; 2001; (3):CD000542. PubMed ID: 11686966
[TBL] [Abstract][Full Text] [Related]
57. Metastatic Crohn's disease: a case report.
Cummins RE; Mullins D; Smith LJ; Ford MJ
Pediatr Dermatol; 1996; 13(1):25-8. PubMed ID: 8919520
[TBL] [Abstract][Full Text] [Related]
58. Glutamine for induction of remission in Crohn's disease.
Akobeng AK; Elawad M; Gordon M
Cochrane Database Syst Rev; 2016 Feb; 2(2):CD007348. PubMed ID: 26853855
[TBL] [Abstract][Full Text] [Related]
59. [A comparison of clinical and pathologic characteristics between Crohn's disease and intestinal tuberculosis].
Gu Q; Ouyang Q; Zhang WY; Li GD
Zhonghua Nei Ke Za Zhi; 2009 Apr; 48(4):291-4. PubMed ID: 19576117
[TBL] [Abstract][Full Text] [Related]
60. Budesonide for induction of remission in Crohn's disease.
Rezaie A; Kuenzig ME; Benchimol EI; Griffiths AM; Otley AR; Steinhart AH; Kaplan GG; Seow CH
Cochrane Database Syst Rev; 2015 Jun; 2015(6):CD000296. PubMed ID: 26039678
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
